Exon skipping with morpholino oligomers: new treatment option for cardiomyopathy in Duchenne muscular dystrophy?

Cardiovasc Res. 2010 Feb 1;85(3):409-10. doi: 10.1093/cvr/cvp397. Epub 2009 Dec 14.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Cardiomyopathies / therapy*
  • Dystrophin / genetics*
  • Exons / genetics*
  • Genetic Therapy / methods*
  • Humans
  • Morpholines / administration & dosage*
  • Morpholinos
  • Muscular Dystrophy, Duchenne / complications
  • Muscular Dystrophy, Duchenne / genetics
  • Muscular Dystrophy, Duchenne / therapy*
  • Oligonucleotides, Antisense

Substances

  • Dystrophin
  • Morpholines
  • Morpholinos
  • Oligonucleotides, Antisense